Human observational studies have reported increased cancer mortality in those with obesity and T2DM, which may be at least in part explained by hyperinsulinemia, elevated insulin-like growth factor-1 (IGF-1), or potentially both53–55. The gene discussed is IGF1; the disease is obesity due to melanocortin 4 receptor deficiency.